Psychedelic-Assisted Therapy in the Post-Pandemic Era
In the wake of Covid-19, psychedelic-assisted therapy is gaining attention.
Anxiety
Psilocybin to Treat Anxiety and Depression in Cancer Patients
Psychedelic Science Review Editor Barb Bauer conducts a review of some landmark studies.
The Structure and Function of the Serotonin 5-HT2C Receptor
5-HT2C has a role in the psychedelic effect. Understanding it is essential for harnessing the full benefits of nature’s chemical cocktails.
Positive Effects of Single-Dose Psilocybin Last Nearly 5 Years
After 4.5 years, 60-80% of the study participants with life-threatening cancer still experienced significantly decreased anxiety or antidepressant effects.
Psilocybin Mushroom Extract More Effective Than Pure Psilocybin in Reducing OCD Symptoms in Mice
This study provides more evidence for the entourage effect in magic mushrooms.
Single Inhalation of Dried Toad Secretions Provides Sub-Acute and Sustained Benefits
Increased mindfulness and decreased anxiety, depression, and stress were seen right away, becoming more significant four weeks after dosing.
Studies Find 5-MeO-DMT Improves Symptoms of Anxiety and Depression
Improvements in depression and anxiety are associated with greater intensity of mystical experiences and higher ratings of the spiritual significance and personal meaning.
TheraPsil Seeks Permission From Health Canada to Use Psilocybin Treatments for Dying Patients
Bruce Tobin is asking Health Canada to approve psilocybin to treat anxiety and depression in end-of-life patients.